On May 25, 2021, Cisema and Advamed cohosted a webinar on China’s digital healthcare economy and relevant regulatory framework.
Mr. Hamish King, Chief Operating Officer of Cisema, led the discussion to present on the market opportunities and regulatory implications of the fast-growing digital healthcare sector in China. Covid-19 has only served to further accelerate favorable market tailwinds. Telehealth, AI and other key digital health trends in China were discussed, and the regulatory framework was analyzed.
Agenda / Topics
1. Digital Healthcare sector in China and recent updates
2. Regulatory pathways for medical devices and IVDs with the China National Medical Products Administration (NMPA, formerly CFDA)
3. Cyber security
4. SaMD registration in China
5. Alternative regulatory pathways
6. Q&A
Before the webinar ended, our Cisema’s experts answered questions to help equip the participants interested in accessing into China’s digital health market.
